Key Factors Affecting Stability in Formulations
| Risk Factor | Effect | Formulation Recommendation |
|---|---|---|
| pH deviation | Strong acids/alkalis may disrupt Cu²⁺ coordination | Maintain pH 5.5–7.0, preferably 6.0–7.0 |
| High temperature | Accelerates peptide degradation and complex inactivation | Add at <40–45°C; avoid high-temperature homogenization or sterilization |
| Light/air exposure | Promotes oxidation and discoloration | Use light-protected, sealed, low-headspace packaging |
| Long-term aqueous storage | Activity declines faster in liquid systems | Consider freeze-dried, single-dose, dry-wet separated, or microencapsulated formats |
| Metal ions/chelators | May compete for copper ions or shift complex equilibrium | Use EDTA-type chelators cautiously; confirm with accelerated stability testing |
Ingredients to Avoid or Use with Caution
Strong acid systems: AHAs, salicylic acid, azelaic acid, and low-pH pure vitamin C may destabilize the complex and release free copper ions.
Strong reducing/oxidizing systems: High-concentration pure vitamin C, benzoyl peroxide, and similar actives may trigger redox reactions, leading to discoloration and inactivation.
Retinoids: Retinol, tretinoin, and retinoid derivatives are generally not recommended for layering with GHK-Cu in the same step; time-separated or compartmentalized use is preferred.
Chelating agents: Disodium EDTA, caprylhydroxamic acid, and similar chelators may compete for copper binding. Whether inactivation occurs depends on concentration and formulation environment, but caution is required.
Certain anionic polymers/thickeners: Carbomer and related systems may interact with copper ions, affecting clarity, viscosity, or overall stability.
Carnosine, ergothioneine, and other strong ligand-prone actives: Data are not fully consistent; if co-formulated, small-scale trials and accelerated stability testing are necessary.
Preferred Stabilization Strategies
Freeze-dried, single-dose, or dry-wet separated formats: Solid-state or just-before-use mixing significantly reduces aqueous degradation risk.
Liposomes, microcapsules, or nanocarriers: These can reduce direct contact between GHK-Cu and incompatible ingredients while supporting skin delivery.
Simplified formulas: Pair with gentle hydrating and barrier-supporting ingredients such as sodium hyaluronate, panthenol, ceramides, and glycerin to lower compatibility risks.
Low-temperature late-stage addition: Add GHK-Cu after emulsification/mixing when the temperature has dropped below 40°C, and avoid prolonged high-shear processing.
Light-protected sealed packaging: Prefer opaque bottles, airless pumps, ampoules, or BFS single-dose units to minimize oxygen and light exposure.
